Conference Call To Discuss Top Line Results From SPARC

January 24, 2018
Time: 08:30 AM EST

Cerus will host a conference call to discuss the top-line results from SPARC, a Phase 3 study evaluating the safety and efficacy of INTERCEPT treated red blood cells in thalassemia patients. 

You may access the live conference call by dialing (866) 235-9006 (U.S.) or (631) 291-4549 (international).

A replay will be available on the company‚Äôs website, or by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and entering conference ID number 4961559.  The replay will be available approximately three hours after the call through February 7, 2018.



  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000
  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600